| Literature DB >> 27476124 |
Abstract
Over the last 2 decades the evolution of alpha-blockers for lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH) has been to preserve effectiveness, improve tolerability, and eliminate dose titration. Today, alpha-blockers represent the first-line treatment of most men with BPH whereby the primary objective is relief from bothersome LUTS.Entities:
Keywords: Alpha-blockers; BPH; Lower urinary tract symptoms; Medical management BPH
Mesh:
Substances:
Year: 2016 PMID: 27476124 DOI: 10.1016/j.ucl.2016.04.009
Source DB: PubMed Journal: Urol Clin North Am ISSN: 0094-0143 Impact factor: 2.241